BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

638 related articles for article (PubMed ID: 29595039)

  • 21. An initial negative round of targeted biopsies in men with highly suspicious multiparametric magnetic resonance findings does not exclude clinically significant prostate cancer-Preliminary experience.
    Costa DN; Kay FU; Pedrosa I; Kolski L; Lotan Y; Roehrborn CG; Hornberger B; Xi Y; Francis F; Rofsky NM
    Urol Oncol; 2017 Apr; 35(4):149.e15-149.e21. PubMed ID: 27939349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of free-hand transperineal mpMRI/TRUS fusion-guided biopsy with transperineal 12-core systematic biopsy for the diagnosis of prostate cancer: a single-center prospective study in China.
    Zhang Q; Wang W; Zhang B; Shi J; Fu Y; Li D; Guo S; Zhang S; Huang H; Jiang X; Zhou W; Guo H
    Int Urol Nephrol; 2017 Mar; 49(3):439-448. PubMed ID: 28005230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Multiparametric Magnetic Resonance Imaging and Targeted Biopsy With Systematic Biopsy Alone for the Diagnosis of Prostate Cancer: A Systematic Review and Meta-analysis.
    Elwenspoek MMC; Sheppard AL; McInnes MDF; Merriel SWD; Rowe EWJ; Bryant RJ; Donovan JL; Whiting P
    JAMA Netw Open; 2019 Aug; 2(8):e198427. PubMed ID: 31390032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of magnetic resonance imaging techniques used to secure biopsies in prostate cancer patients.
    van Luijtelaar A; Bomers J; Fütterer J
    Expert Rev Anticancer Ther; 2019 Aug; 19(8):705-716. PubMed ID: 31277551
    [No Abstract]   [Full Text] [Related]  

  • 25. The feasibility of multiparametric magnetic resonance imaging for targeted biopsy using novel navigation systems to detect early stage prostate cancer: the preliminary experience.
    Mouraviev V; Verma S; Kalyanaraman B; Zhai QJ; Gaitonde K; Pugnale M; Donovan JF
    J Endourol; 2013 Jul; 27(7):820-5. PubMed ID: 22966987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of the Role of Negative Magnetic Resonance Imaging of the Prostate in Clinical Practice: Is Biopsy Still Necessary?
    Wang RS; Kim EH; Vetter JM; Fowler KJ; Shetty AS; Mintz AJ; Badhiwala NG; Grubb RL; Andriole GL
    Urology; 2017 Apr; 102():190-197. PubMed ID: 27845218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High diagnostic ability of multiparametric magnetic resonance imaging to detect anterior prostate cancer missed by transrectal 12-core biopsy.
    Komai Y; Numao N; Yoshida S; Matsuoka Y; Nakanishi Y; Ishii C; Koga F; Saito K; Masuda H; Fujii Y; Kawakami S; Kihara K
    J Urol; 2013 Sep; 190(3):867-73. PubMed ID: 23542406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen.
    Radtke JP; Schwab C; Wolf MB; Freitag MT; Alt CD; Kesch C; Popeneciu IV; Huettenbrink C; Gasch C; Klein T; Bonekamp D; Duensing S; Roth W; Schueler S; Stock C; Schlemmer HP; Roethke M; Hohenfellner M; Hadaschik BA
    Eur Urol; 2016 Nov; 70(5):846-853. PubMed ID: 26810346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are concurrent systematic cores needed at the time of targeted biopsy in patients with prior negative prostate biopsies?
    Albisinni S; Aoun F; Noel A; El Rassy E; Lemort M; Paesmans M; van Velthoven R; Roumeguère T; Peltier A
    Prog Urol; 2018 Jan; 28(1):18-24. PubMed ID: 29203158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnetic resonance imaging-targeted vs. conventional transrectal ultrasound-guided prostate biopsy: single-institution, matched cohort comparison.
    Kim EH; Vemana G; Johnson MH; Vetter JM; Rensing AJ; Strother MC; Fowler KJ; Andriole GL
    Urol Oncol; 2015 Mar; 33(3):109.e1-6. PubMed ID: 25655682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The value of magnetic resonance imaging and ultrasonography (MRI/US)-fusion biopsy platforms in prostate cancer detection: a systematic review.
    Gayet M; van der Aa A; Beerlage HP; Schrier BP; Mulders PF; Wijkstra H
    BJU Int; 2016 Mar; 117(3):392-400. PubMed ID: 26237632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnetic resonance imaging-guided prostate biopsy: present and future.
    Kim CK
    Korean J Radiol; 2015; 16(1):90-8. PubMed ID: 25598677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnetic resonance imaging targeted biopsy in men with previously negative prostate biopsy results.
    Lee SH; Chung MS; Kim JH; Oh YT; Rha KH; Chung BH
    J Endourol; 2012 Jul; 26(7):787-91. PubMed ID: 22122555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound-fusion biopsy for the diagnosis of prostate cancer.
    Borkowetz A; Platzek I; Toma M; Laniado M; Baretton G; Froehner M; Koch R; Wirth M; Zastrow S
    BJU Int; 2015 Dec; 116(6):873-9. PubMed ID: 25523210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12-core biopsy still necessary in addition to a targeted biopsy?
    Salami SS; Ben-Levi E; Yaskiv O; Ryniker L; Turkbey B; Kavoussi LR; Villani R; Rastinehad AR
    BJU Int; 2015 Apr; 115(4):562-70. PubMed ID: 25252133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imaging in prostate cancer diagnosis: present role and future perspectives.
    Pinto F; Totaro A; Calarco A; Sacco E; Volpe A; Racioppi M; D'Addessi A; Gulino G; Bassi P
    Urol Int; 2011; 86(4):373-82. PubMed ID: 21372554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Magnetic resonance imaging-guided biopsies may improve diagnosis in biopsy-naive men with suspicion of prostate cancer.
    Winther MD; Balslev I; Boesen L; Logager V; Noergaard N; Thestrup KD; Thomsen HS
    Dan Med J; 2017 May; 64(5):. PubMed ID: 28552089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Value of Endorectal Magnetic Resonance Imaging of the Prostate in Improving the Detection of Anterior Prostate Cancer.
    Zugor V; Kühn R; Engelhard K; Poth S; Bernat MM; Porres D; Labanaris AP
    Anticancer Res; 2016 Aug; 36(8):4279-83. PubMed ID: 27466544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison between target magnetic resonance imaging (MRI) in-gantry and cognitively directed transperineal or transrectal-guided prostate biopsies for Prostate Imaging-Reporting and Data System (PI-RADS) 3-5 MRI lesions.
    Yaxley AJ; Yaxley JW; Thangasamy IA; Ballard E; Pokorny MR
    BJU Int; 2017 Nov; 120 Suppl 3():43-50. PubMed ID: 28749035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic ultrasound-guided saturation and template biopsy of the prostate: indications and advantages of extended sampling.
    Isbarn H; Briganti A; De Visschere PJ; Fütterer JJ; Ghadjar P; Giannarini G; Ost P; Ploussard G; Sooriakumaran P; Surcel CI; van Oort IM; Yossepowitch O; van den Bergh RC;
    Arch Esp Urol; 2015 Apr; 68(3):296-306. PubMed ID: 25948801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.